TuHURA Biosciences Inc (HURA) — Cash Flow-to-Debt Ratio
TuHURA Biosciences Inc (HURA) has a Cash Flow-to-Debt Ratio of -0.87x as of December 2025, meaning its operating cash flow of $-5.56 Million could theoretically repay -1% of its total liabilities ($6.42 Million) in one year. See working capital to net assets of TuHURA Biosciences Inc to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TuHURA Biosciences Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for TuHURA Biosciences Inc across 11 annual periods. Also explore TuHURA Biosciences Inc (HURA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for TuHURA Biosciences Inc (2015–2025)
Year-by-year debt coverage analysis for TuHURA Biosciences Inc. For market capitalisation and broader financial context, see market value of TuHURA Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.74x | $-14.73 Million | $5.37 Million | ▼ -126.2% |
| 2024 | -1.21x | $-7.18 Million | $5.92 Million | ▲ +53.3% |
| 2023 | -2.60x | $-7.51 Million | $2.89 Million | ▼ -182.8% |
| 2022 | -0.92x | $-6.56 Million | $7.15 Million | ▲ +85.6% |
| 2021 | -6.37x | $-18.86 Million | $2.96 Million | ▼ -114.8% |
| 2020 | -2.96x | $-7.93 Million | $2.67 Million | ▲ +3.1% |
| 2019 | -3.06x | $-6.33 Million | $2.07 Million | ▲ +49.1% |
| 2018 | -6.01x | $-9.85 Million | $1.64 Million | ▲ +0.2% |
| 2017 | -6.02x | $-8.02 Million | $1.33 Million | ▼ -75.1% |
| 2016 | -3.44x | $-5.15 Million | $1.50 Million | ▼ -203.0% |
| 2015 | -1.13x | $-3.85 Million | $3.40 Million | — |